Vice President, Translational Research jobs in United States
cer-icon
Apply on Employer Site
company-logo

Rhythm Pharmaceuticals Inc. · 2 days ago

Vice President, Translational Research

Rhythm Pharmaceuticals Inc. is a global biopharmaceutical company focused on transforming the lives of patients with rare neuroendocrine diseases. They are seeking a Vice President of Translational Research to provide strategic and scientific leadership across non-clinical functions and to shape the non-clinical strategy for the development of small molecule therapies.

BiotechnologyPharmaceuticalTherapeutics
check
H1B Sponsor Likelynote

Responsibilities

Provide strategic leadership for all non-clinical functions, including toxicology, clinical pharmacology, and exploratory biology
Drive exploratory research initiatives to elucidate mechanisms of action, identify new therapeutic opportunities, and inform lifecycle management strategies
Ensure a translational approach to research, integrating non-clinical and clinical insights to optimize development strategies
Partner closely with the CSO and executive leadership to shape overall scientific strategy and ensure alignment with corporate objectives
Collaborate with senior leaders across clinical development, regulatory affairs, data sciences, and commercial to drive cross-functional decision-making
Oversee the design, execution, and interpretation of non-clinical studies supporting IND, early clinical development, and regulatory submissions
Represent non-clinical research in regulatory interactions and contribute to the preparation and review of submission documents
Build and mentor a high-performing team, ensuring scientific excellence and operational rigor
Stay abreast of emerging science and regulatory trends to maintain a competitive edge in rare disease and neuroendocrine drug development

Qualification

Ph.D.Equivalent15+ years R&D experienceINDNDA filingsNeuroendocrinologyTranslational researchRegulatory requirements knowledgeMulti-disciplinary team leadershipEntrepreneurial mindsetScientific curiosityCollaboration skillsCommunication skills

Required

Ph.D., M.D., D.V.M., or equivalent in Pharmacology, Toxicology, Biology, or related discipline
15+ years of experience in pharmaceutical or biotechnology R&D, with significant leadership responsibility in non-clinical development
Experience of early stage clinical development
Track record of successful IND and NDA filings
Demonstrated expertise in obesity, metabolism, and neuroendocrinology
Proven ability to translate non-clinical findings into clinical strategy and influence portfolio decisions
Deep understanding of regulatory requirements for non-clinical development and experience engaging with global health authorities
Exceptional ability to influence, collaborate, and communicate across all levels of the organization
Experience leading multi-disciplinary teams in a matrixed environment
Entrepreneurial mindset with a passion for innovation and patient impact
Strong scientific curiosity and ability to translate emerging biology into actionable development strategies

Preferred

Experience in rare disease drug development strongly preferred

Benefits

Discretionary annual bonus
Restricted stock units

Company

Rhythm Pharmaceuticals Inc.

twittertwittertwitter
company-logo
Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on transforming the lives of patients with rare neuroendocrine diseases by rapidly advancing care and precision medicines that address the root cause.

H1B Sponsorship

Rhythm Pharmaceuticals Inc. has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (1)
2023 (1)
2022 (4)

Funding

Current Stage
Public Company
Total Funding
$1.22B
Key Investors
HealthCare Royalty Partners
2025-07-10Post Ipo Equity· $175M
2024-04-01Post Ipo Debt· $150M
2022-09-14Post Ipo Equity· $124.8M

Leadership Team

leader-logo
Elisabeth Crönert-Bendell
SVP, Head of Strategy
linkedin
Company data provided by crunchbase